Publication | Closed Access

Hyaluronic acid modified liposomes for targeted delivery of doxorubicin and paclitaxel to CD44 overexpressing tumor cells with improved dual-drugs synergistic effect

Cell-based Drug DeliveryNanomedicineDrug TargetingEngineeringHyaluronic AcidTargeted DeliveryMedicinePolymer-drug ConjugateTumor CellsNano-drug DeliveryTumor TargetingBiomedical EngineeringMatrix BiologyPharmacologyTumor Biology